Microvascular disorders in obese Zucker rats are restored by a rice bran diet

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 5, 2014, Pages 524-531

  Justo, M L ^a   Claro, C ^a   Vila, E ^b   Herrera, M D ^a   Rodriguez Rodriguez, R ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Mesenteric artery; Microvascular function; Obese zucker rat; Obesity; Rice bran

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITROUS OXIDE; PLANT EXTRACT; RICE BRAN EXTRACT; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADIPONECTIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; NITRIC OXIDE; NOS3 PROTEIN, RAT; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DIET SUPPLEMENTATION; IMMUNOBLOTTING; MESENTERIC ARTERY; MICROVASCULAR ISCHEMIA; MYOGRAPHY; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; VASODILATATION; ADMINISTRATION AND DOSAGE; ANIMAL; BLOOD; BLOOD PRESSURE; CHEMISTRY; DIET; DIET THERAPY; DIETARY FIBER; DYSLIPIDEMIA; GENETICS; GLUCOSE BLOOD LEVEL; HYPERINSULINISM; HYPERTENSION; METABOLISM; RICE; ZUCKER RAT;

RATTUS;

ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL, HDL; DIET; DIETARY FIBER; DYSLIPIDEMIAS; HYPERINSULINISM; HYPERTENSION; INSULIN; INTERLEUKIN-1BETA; INTERLEUKIN-6; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OBESITY; ORYZA SATIVA; RATS; RATS, ZUCKER; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84898818085     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2013.10.032     Document Type: Article

References (30)

1. Bagi Z., Feher A., Cassuto J. Microvascular responsiveness in obesity: implications for therapeutic intervention. Br J Pharmacol 2012, 165(3):544-560.
2. Jonk A.M., Houben A.J., de Jongh R.T., Serné E.H., Schaper N.C., Stehouwer C.D. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Physiology (Bethesda) 2007, 22:252-260.
3. Hornstra J.M., Serné E.H., Eringa E.C., Wijnker M.C., de Boer M.P., Yudkin J.S., et al. Insulin's microvascular vasodilatory effects are inversely related to peripheral vascular resistance in overweight, but insulin-sensitive subjects. Obesity (Silver Spring) 2013, 10.1002/oby.20406.
4. Haddock R.E., Grayson T.H., Morris M.J., Howitt L., Chadha P.S., Sandow S.L. Diet-induced obesity impairs endothelium-derived hyperpolarization via altered potassium channel signaling mechanisms. PLoS One 2011, 6(1):e16423.
5. Tesauro M., Cardillo C. Obesity, blood vessels and metabolic syndrome. Acta Physiol (Oxf) 2011, 203:279-286.
6. Del Prato S. Megatrials in type 2 diabetes. From excitement to frustration?. Diabetologia 2009, 52(7):1219-1226.
7. Davì G., Santilli F., Patrono C. Nutraceuticals in diabetes and metabolic syndrome. Cardiovasc Ther 2010, 28(4):216-226.
8. Babio N., Bulló M., Basora J., Martínez-González M.A., Fernández-Ballart J., Márquez-Sandoval F., et al. Adherence to the Mediterranean diet and risk of metabolic syndrome and its components. Nutr Metab Cardiovasc Dis 2009, 19(8):563-570. Nureta-PREDIMED Investigators.
9. Abete I., Goyenechea E., Zulet M.A., Martínez J.A. Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutr Metab Cardiovasc Dis 2011, S2:B1-B15.
10. Salas-Salvadó J., Martinez-González M.Á., Bulló M., Ros E. The role of diet in the prevention of type 2 diabetes. Nutr Metab Cardiovasc Dis 2011, 21(Suppl. 2):B32-B48.
11. Agouni A., Lagrue-Lak-Hal A.H., Mostefai H.A., Tesse A., Mulder P., Rouet P., et al. Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa). PLoS One 2009, 4(5):e5557.
12. Islam M.S., Nagasaka R., Ohara K., Hosoya T., Ozaki H., Ushio H., et al. Biological abilities of rice bran-derived antioxidant phytochemicals for medical therapy. Curr Top Med Chem 2011, 11:1847-1853.
13. Parrado J., Miramontes E., Jover M., Gutiérrez J.F., Collantes de Teran L., Bautista J. Preparation of a rice bran enzymatic extract with potential use as functional food. Food Chemistry 2006, 98:742-748.
14. Justo M.L., Rodriguez-Rodriguez R., Claro C.M., Alvarez de Sotomayor M., Parrado J., Herrera M.D. Water-soluble rice bran enzymatic extract attenuates dyslipidemia, hypertension and insulin resistance in obese Zucker rats. Eur J Nutr 2013, 52(2):789-797.
15. Justo M.L., Candiracci M., Dantas A.P., de Sotomayor M.A., Parrado J., Vila E., et al. Rice bran enzymatic extract restores endothelial function and vascular contractility in obese rats by reducing vascular inflammation and oxidative stress. J Nutr Biochem 2013, 24(8):1453-1461.
16. Berger A., Rein D., Schäfer A., Monnard I., Gremaud G., Lambelet P., et al. Similar cholesterol-lowering properties of rice bran oil, with varied gamma-oryzanol, in mildly hypercholesterolemic men. Eur J Nutr 2005, 44(3):163-173.
17. Accinni R., Rosina M., Bamonti F., Della Noce C., Tonini A., Bernacchi F., et al. Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects. Nutr Metab Cardiovasc Dis 2006, 16(2):121-127.
18. Ardiansyah Shirakawa H., Koseki T., Hashizume K., Komai M. The Driselase-treated fraction of rice bran is a more effective dietary factor to improve hypertension, glucose and lipid metabolism in stroke-prone spontaneously hypertensive rats compared to ferulic acid. Br J Nutr 2007, 97(1):67-76.
19. Wilson T.A., Nicolosi R.J., Woolfrey B., Kritchevsky D. Rice bran oil and oryzanol reduce plasma lipid and lipoprotein cholesterol concentrations and aortic cholesterol ester accumulation to a greater extent than ferulic acid in hypercholesterolemic hamsters. J Nutr Biochem 2007, 18(2):105-112.
20. Rodriguez-Rodriguez R., Herrera M.D., de Sotomayor M.A., Ruiz-Gutierrez V. Effects of pomace olive oil-enriched diets on endothelial function of small mesenteric arteries from spontaneously hypertensive rats. Br J Nutr 2009, 102(10):1435-1444.
21. Kozuka C., Yabiku K., Takayama C., Matsushita M., Shimabukuro M. Natural food science based novel approach toward prevention and treatment of obesity and type 2 diabetes: recent studies on brown rice and γ-oryzanol. Obes Res Clin Pract 2013, 7(3):e165-e172.
22. Virdis A., Santini F., Colucci R., Duranti E., Salvetti G., Rugani I., et al. Vascular generation of tumor necrosis factor-α reduces nitric oxide availability in small arteries from visceral fat of obese patients. J Am Coll Cardiol 2011, 58(3):238-247.
23. Young E.J., Hill M.A., Wiehler W.B., Triggle C.R., Reid J.J. Reduced EDHF responses and connexin activity in mesenteric arteries from the insulin-resistant obese Zucker rat. Diabetologia 2008, 51(5):872-881.
24. Ozkor M.A., Quyyumi A.A. Endothelium-derived hyperpolarizing factor and vascular function. Cardiol Res Pract 2011, 2011:156146. 10.4061/2011/156146.
25. Grgic I., Kaistha B.P., Hoyer J., Köhler R. Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses-relevance to cardiovascular pathologies and drug discovery. Br J Pharmacol 2009, 157(4):509-526.
26. Cauwels A., Rogge E., Janssen B., Brouckaert P. Reactive oxygen species and small-conductance calcium-dependent potassium channels are key mediators of inflammation-induced hypotension and shock. J Mol Med (Berl) 2010, 88(9):921-930.
27. Burnham M.P., Johnson I.T., Weston A.H. Impaired small-conductance Ca2+-activated K+ channel-dependent EDHF responses in Type II diabetic ZDF rats. Br J Pharmacol 2006, 148(4):434-441.
28. Gaete P.S., Lillo M.A., Ardiles N.M., Pérez F.R., Figueroa X.F. Ca2+-activated K+ channels of small and intermediate conductance control eNOS activation through NAD(P)H oxidase. Free Radic Biol Med 2012, 52(5):860-870.
29. Gregor M.F., Hotamisligil G.S. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011, 29:415-445.
30. Virdis A., Neves M.F., Duranti E., Bernini G., Taddei S. Microvascular endothelial dysfunction in obesity and hypertension. Curr Pharm Des 2013, 19(13):2382-2389.